Published on 5 Oct 2021 on Benzinga
Why Ocugen Shares Are Trading Higher Today
Ocugen Inc (NASDAQ: OCGN) is trading higher Tuesday after a company 8-K showed it entered into a Development and Commercial Supply Agreement with Bharat Biotech pursuant to which Bharat Biotech will exclusively manufacture and supply the company with its requirements of COVAXIN clinical trial materials as well as manufacture and supply COVAXIN drug product components.
The World Health Organization is set to decide on the Emergency Use Listing authorization of COVAXIN today. COVAXIN is India's indigenously-developed COVID-19 vaccine, in collaboration with Ocugen.